Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Common Stock | Options Exercise | +2.48K | +13.17% | 21.3K | Aug 10, 2021 | Direct | F1 | ||
transaction | GILD | Common Stock | Tax liability | -$62.8K | -907 | -4.26% | $69.24 | 20.4K | Aug 10, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GILD | Restricted Stock Unit | Options Exercise | -2.48K | -13.49% | 15.9K | Aug 10, 2021 | Common Stock | 2.48K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
F2 | The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested. |